Cero Therapeutics Holdings CERO
OTC CERO
$0.00 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Cero Therapeutics Holdings, Inc. (CERO) Share-based Compensation (2023 - 2026)

Updated

Cero Therapeutics Holdings (CERO) reported Share-based Compensation of $1.12 million for Q2 2026, up 512.1% from $183,328 a year earlier but down 30.6% from the prior quarter.

Analysis

Cero Therapeutics Holdings, Inc. (CERO) Share-based Compensation (2023 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Cero Therapeutics Holdings' Share-based Compensation came in at $3.35 million; for FY2025, it came in at $1.1 million, up 18.5% from FY2024.

  • By year, Share-based Compensation came in at $924,668 in FY2024 (+854.3%) and $96,896 in FY2023.
  • Five-year quarterly Share-based Compensation spans a low of -$975,103 in Q4 2024 and a high of $1.62 million in Q1 2026.
  • Year over year, Share-based Compensation gained in three of the last five quarters, with growth averaging 211.3%.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $1.62 million (Q1 2026), $259,666 (Q4 2025) and $348,116 (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.12 Mn
Mar 31, 2026 1.62 Mn
Dec 31, 2025 259,666.00
Sep 30, 2025 348,116.00
Jun 30, 2025 707,300.00
Mar 31, 2025 304,946.00
Dec 31, 2024 -975,103.00
Sep 30, 2024 400,000.00
Jun 30, 2024 30,000.00
Mar 31, 2024 90,000.00
Dec 31, 2023 16,896.00
Sep 30, 2023 20,000.00
Jun 30, 2023 1.40 Mn
Mar 31, 2023 28,144.00
API Access

Cero Therapeutics Holdings, Inc. Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CERO&period=max&api_key=YOUR_API_KEY